Related Experiment Videos
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro"
A Fattorossi1, A Dolei, J G Pizzolo
1Institute of Virology, University of Rome, La Sapienza, Italy.
Journal of Biological Regulators and Homeostatic Agents
|April 1, 1987
Summary
Interferon-alpha (IFN-alpha) treatment selectively alters hairy cell leukemia cells in vitro, reducing key enzymes and surface markers. These changes suggest a potential mechanism for IFN-alpha
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Hairy cell leukemia (HCL) is a rare B-cell chronic lymphoid leukemia.
- Interferon-alpha (IFN-alpha) is a cytokine used in HCL treatment.
- Understanding IFN-alpha's cellular effects is crucial for optimizing therapy.
Purpose of the Study:
- To investigate the in vitro effects of IFN-alpha on the phenotypic profile of hairy cells.
- To determine how IFN-alpha influences cellular markers and enzyme activity in HCL.
Main Methods:
- Hairy cells from 5 HCL patients were cultured for 72 hours with IFN-alpha.
- Cytochemical analysis assessed enzyme activity (acid phosphatase, tartrate-resistant acid phosphatase).
- Flow cytometry evaluated surface marker expression (immunoglobulins, Fc receptors, MHC class II, OKT10, PCA-1).
Main Results:
- IFN-alpha significantly decreased acid phosphatase and tartrate-resistant acid phosphatase.
- Surface immunoglobulin density was reduced by IFN-alpha, without changing isotype.
- Fc receptor expression decreased, while MHC class II antigen expression remained unchanged.
Conclusions:
- IFN-alpha consistently and selectively affects membrane and cytoplasmic features of hairy cells in vitro.
- Observed cellular changes may correlate with the therapeutic efficacy of IFN-alpha in HCL.